Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MBIO

Mustang Bio

$7.32

0.08 (1.11%)

, FBIO

Fortress Biotech

$2.70

-0.105 (-3.75%)

08:36
07/19/18
07/19
08:36
07/19/18
08:36
Hot Stocks
Mustang Bio completes pre-IND meeting with FDA for MB-102 »

Mustang Bio (MBIO), a…

MBIO

Mustang Bio

$7.32

0.08 (1.11%)

FBIO

Fortress Biotech

$2.70

-0.105 (-3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRNS

Marinus Pharmaceuticals

$7.85

-0.04 (-0.51%)

06:18
07/19/18
07/19
06:18
07/19/18
06:18
Recommendations
Marinus Pharmaceuticals analyst commentary at Mizuho »

Marinus can rally 100% on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Wednesday
KPTI

Karyopharm

$18.47

0.12 (0.65%)

07:03
07/18/18
07/18
07:03
07/18/18
07:03
Hot Stocks
Karyopharm initiates rolling submission of NDA to FDA for selinexor »

Karyopharm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYRS

Syros Pharmaceuticals

$12.74

(0.00%)

04:55
07/18/18
07/18
04:55
07/18/18
04:55
Conference/Events
Syros Pharmaceuticals management to meet with Piper Jaffray »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

Tuesday
SYRS

Syros Pharmaceuticals

$13.12

0.38 (2.98%)

14:29
07/17/18
07/17
14:29
07/17/18
14:29
Recommendations
Syros Pharmaceuticals analyst commentary at Piper Jaffray »

Piper reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

SYRS

Syros Pharmaceuticals

$12.74

0.39 (3.16%)

08:25
07/17/18
07/17
08:25
07/17/18
08:25
Conference/Events
Syros Pharmaceuticals to hold a key opinion leader meeting »

Key Opinion Leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

SYRS

Syros Pharmaceuticals

$12.74

0.39 (3.16%)

04:55
07/17/18
07/17
04:55
07/17/18
04:55
Conference/Events
Syros Pharmaceuticals to hold a key opinion leader meeting »

Key Opinion Leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

Monday
SYRS

Syros Pharmaceuticals

$12.35

(0.00%)

14:08
07/16/18
07/16
14:08
07/16/18
14:08
Conference/Events
Syros Pharmaceuticals to hold a key opinion leader meeting »

Key Opinion Leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SLGL

Sol-Gel Technologies

$6.88

0.37 (5.68%)

07:09
07/16/18
07/16
07:09
07/16/18
07:09
Initiation
Sol-Gel Technologies initiated at H.C. Wainwright »

Sol-Gel Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYRS

Syros Pharmaceuticals

$12.35

-0.01 (-0.08%)

06:55
07/16/18
07/16
06:55
07/16/18
06:55
Conference/Events
Syros Pharmaceuticals management to meet with Piper Jaffray »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.